Viewing Study NCT00381602


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:01 AM
Study NCT ID: NCT00381602
Status: TERMINATED
Last Update Posted: 2011-04-04
First Post: 2006-09-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
Sponsor: QLT Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-09
Start Date Type: None
Primary Completion Date: 2007-05
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2006-09-26
First Submit QC Date: None
Study First Post Date: 2006-09-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2011-03-16
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2011-03-25
Last Update Post Date: 2011-04-04
Last Update Post Date Type: ESTIMATED